BioClinica bites back at Nicusa Capital's call for leadership changes

BioClinica bites back at Nicusa Capital's call for leadership changes

6 Minuten

Beschreibung

vor 15 Jahren
Mark Weinstein, CEO of Bioclinica, has hit back at a public letter
from Nicusa Capital CEO, Paul Johnson, claiming that the company's
corporate strategy is 'flawed' and demanding the resignation of
three top executives.

Kommentare (0)

Lade Inhalte...

Abonnenten

15
15